Five decades after its first description by Gass and despite improved technology for retinal imaging and therapeutic options such as the injection of anti-vascular endothelial growth factor (VEGF) agents, AMD is a leading cause of irreversible visual impairment. As the population continues to age, the number of patients with neovascular AMD are projected to rise. A recent article of Spaide et al. provides a comprehensive overview on definitions, , classification and references, supported by numerous illustrative figures.
https://www.aaojournal.org/article/S0161-6420(19)32243-2/pdf
Dr. Mueller-Lierheim 